well you are partly correct in that they are part of HCT growth strategy, but way off the mark to say a ‘large’ part
once the other international distribution deals and product lines kick in I would say they are at best like 5% of HCT growth strategy and that’s only if they are really successful.
I’ll still be happy if we end up getting a few mil in revenue from them each year though
Ann: Appendix 4C Quarterly Cashflow Report and Commentary, page-245
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105855 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 282891 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable